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Hyperparathyroidism with Normal Albumin-Corrected Total 
Calcium in Patients with Multiple Endocrine Neoplasia Type 1 
J. J. Shepherd,* Bin Tean Teh,* V. Parameswaran,* and R. David' 
In the largest reported family of patients with multiple endocrine neoplasia type 1 (MEN 1], 
hyperparathyroidism was expressed at first screening in 33 patients by elevation of ionized calcium 
(IC) (30 cases) or parathyroid hormone (three cases) without elevation of albumin-corrected total 
calcium (ACTC). Three ofthese 33 patients have shown a progressive rise in IC and later an elevation 
of ACTC. However, the age distribution suggests that in others the level ofIC may remain stable at a 
minimally elevated level throughout life with ACTC remaining normal except for transient rises at the 
times of intercurrent illness or surgical operation. Even when ACTC is normal preoperatively, 
patients with an elevation of IC require radical subtotal parathyroidectomy or total parathy-
roidectomy and forearm implantation to restore IC to a normal level. Institutions that rely on ACTC 
as a screening test for hyperparathyroidism in MEN I will miss the diagnosis in nearly half of patients 
under the age of 30. The greatest deficiency in using ACTC occurs in the follow-up of patients who 
have undergone parathyroidectomy for MEN I. Only three of 11 recurrences were evidenced by this 
measurement. (Henry Ford Hosp Med J 1992:40:186-90) 
A number of authors (1-3) have suggested that ionized se-rum calcium (IC) may be a better discriminant or elevated 
more consistendy than albumin-corrected total serum calcium 
(ACTC) or parathyroid hormone (PTH) in patients with hyper-
parathyroidism. Previous studies have dealt predominantly with 
middle-aged or elderly patients. The presence of a large family 
(4) of patients in Tasmania with multiple endocrine neoplasia 
type 1 (MEN 1) has made it possible to screen large numbers of 
young patients who are at 50% risk of developing parathyroid 
hyperplasia, as weU as more elderly patients with established 
disease. In the early years of this study, only the total serum cal-
cium was measured and corrected for albumin. At the end of 
1986 an analyzer for ionized calcium (Radiometer, Copen-
hagen) was installed, and in all subsequent screenings at the 
Royal Hobart Hospital both total and ionized fractions have 
been measured. 
A total of 93 members of one family with MEN 1 had shown 
biochemical evidence of hyperparathyroidism by the end of 
1990. In 60 patients this was associated at first screening with el-
evations of ACTC. However, in 33 patients (35%), ACTC was 
found to be normal at first screening. Three of those seen before 
1986 were considered to have hyperparathyroidism on the basis 
of elevation of PTH. In one patient this was confirmed at neck 
exploration. After measurement of IC became available, the 
other two patients with elevated PTH but normal ACTC were 
found to have elevated IC and another 30 patients were identi-
fied with normal ACTC but elevated IC. Most of these had nor-
mal PTH. In some of these patients ACTC was toward the upper 
end of the normal range, but in others it was around the midpoint 
and in a few toward the lower limit of the normal range. It was 
apparent that the acceptance of IC, rather than ACTC, as a 
screening test would result in a substantial increase in numbers 
of patients diagnosed as having MEN 1. We therefore decided to 
review these patients and assess the supporting evidence from 
other sources for the diagnosis of hyperparathyroidism and 
MEN 1 in order to justify a change from the traditional standard 
of elevated ACTC as the basis of diagnosis. 
Patients with elevated ACTC have been compared to those 
with normal ACTC but raised IC or PTH in terms of age, associ-
ation with other manifestations of MEN 1, parentage of affected 
offspring, renal and bone involvement, operative findings, and 
results of surgery. 
Results 
Age 
Elevation of ACTC was seen in MEN 1 patients of all age 
groups, with an age range of 11 to 75 years at first diagnosis (Ta-
ble 1). Elevation of IC with normal ACTC was also seen in 
MEN 1 patients in all age groups (age range of 13 to 81 years at 
first diagnosis) but was more predominant in young patients. Up 
to the age of 30 years, almost half of all patients with elevated IC 
have normal ACTC. Above the age of 30, die majority of pa-
tients with elevated IC also have elevated ACTC, but even in 
this group 28% have normal ACTC. 
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Association with lesions at other sites 
Thirty-three (55%) of the 60 patients with elevated ACTC 
also had evidence of a lesion of the pancreas, pituitary, or adre-
nal or an intrathoracic carcinoid tumor. Seventeen (52%) of the 
33 patients with elevated PTH or IC but normal ACTC had evi-
dence of an endocrine tumor at another site. 
Experience of the Zollinger-Ellison (ZE) syndrome in Tas-
man Family 1 has been the same as that reported in an English 
family (5) where the syndrome only presented in patients who 
had elevation of semm calcium and semm gastrin. In four of our 
symptomatic patients, however, this would not have been de-
tected if the IC had not been measured, because these patients 
had elevated IC but normal ACTC. All of these patients have un-
dergone neck exploration, and all were found to have four-gland 
hyperplasia. Restoration of IC to normal levels has resulted in 
symptomatic improvement and a fall in the level of serum gas-
trin. 
Parenthood 
Thirty-three of the patients with elevated ACTC are 35 years 
old or older. Twenty-three (70%) of these 33 have affected chil-
dren. Sixteen of the patients with elevated IC but normal ACTC 
are 35 years or older. Nine (56%) of these 16 have affected chil-
dren diagnosed with MEN 1. 
Patient 646 in Tasman Family 1 genealogy 9 had seven sons 
and two daughters (4). He had normal prolactin, normal gastrin, 
and normal ACTC at first testing in 1984. IC was first estimated 
in 1987 when this patient was 81 years old and was found to be 
elevated although ACTC remained normal. One son (patient 
1548) developed "fits" at the age of 19 which was diagnosed as 
epilepsy. Over the next 12 years, he spent long periods under 
psychiatric care and off work. Ultimately surgical exploration 
revealed an insulinoma and two other adenomas in the pancreas. 
This resolved his medical and psychiatric problems. Although a 
daughter (patient 1551) was asymptomatic at first screening for 
MEN 1, she was found to have gross elevation of serum gastrin 
and semm prolactin. Computed tomography showed liver me-
tastasis and erosion of the pituitary fossa. Another son (patient 
1553) had raised ACTC, raised gastrin, and an adrenal adenoma 
at first screening. Four of the grandchildren also are clearly af-
fected with three showing lesions of the pancreas and pituitary 
in addition to hyperparathyroidism. 
Renal and bone involvement 
Eight of the patients with raised ACTC had renal calculi. Four 
of these had nephrocalcinosis and one developed widespread 
cystic bone disease (the single instance of this complication in 
93 patients). 
Only two of the patients with elevated IC but normal ACTC 
developed renal calculi; neither of these patients has nephrocal-
cinosis. However, the case records of one of the patients with 
raised ACTC—patient 1757 bom in 1939 and fully investigated 
in a urology service in 1965 and 1971—clearly show that he de-
veloped multiple calculi and bilateral nephrocalcinosis at a time 
when measurement of ACTC was within the normal range. Fol-
lowing right renal calculus in 1971, he developed left renal cal-
culus in 1972 and had partial nephrectomy for nephrocalcinosis 
Table 1 
Age at Diagnosis of 93 Patients 
with Elevated Serum Calcium 
Age (years) Elevated ACTC Normal ACTC Elevated IC 
10-19 5 6 
20-29 14 1 1 
30-39 16 4 
40-49 11 6 
50-59 7 3 
60-69 6 2 
70-1- 1 1 
Total 60 33 
in 1973. On each occasion the case records show that the diag-
nosis of hyperparathyroidism was considered but that the level 
of ACTC was found to be normal. In 1971, it was 9.3 mg/dL 
(normal 9.0 to 11.4 mg/dL). His family history was not known 
until 1983 when he was first screened for MEN 1. This revealed 
gross elevation of serum prolactin at 184 ug/L (normal 11 (ig/L) 
and elevation of ACTC at 2.73 mmol/L (normal 2.10 to 2.60 
mmol/L). Ionized calcium was not being measured in 1983, but 
it is highly likely from our experience with other family mem-
bers that elevation of IC was present from an early age and at the 
time that his renal problems developed. One of his children, age 
19 years, has a prolactinoma of the pituitary, an adenoma of the 
pancreas, and elevation of IC but not of ACTC or PTH. 
At the age of 44, patient 1757 had ischemic heart disease and 
hypertension which progressed despite parathyroidectomy. At 
the age of 49 he had a debilitating stroke and hemiparesis. 
Findings at surgery 
A total of 54 neck explorations have been conducted in 48 
members of Tasman Family 1. Overall, 44 patients had a single 
neck exploration, three patients had two explorations, and one 
patient had four explorations. 
On 40 occasions surgery was indicated on the basis of symp-
toms associated with elevated ACTC, but 14 patients had nor-
mal ACTC and elevation only of IC. In 39 of the 40 operations 
associated with elevation of ACTC, hyperplasia of all glands 
was either identified at operation or indicated by persistence of 
hypercalcemia after removal of less than 3.5 glands. In one pa-
tient removal of a single enlarged gland has been followed by 
prolonged restoration of normal calcium levels. 
Seven of the patients with elevated ACTC had parathyroid 
glands larger than 3 cm in diameter, and one patient had five of 
eight enlarged parathyroids in excess of 3 cm and two in excess 
of 5 cm in diameter. 
On 14 occasions, surgery has been carried out on patients who 
had normal ACTC but either elevated IC or elevated PTH. Hy-
perplasia of all four glands was identified at first exploration in 
all 14 patients. Only one patient in this group had a parathyroid 
exceeding 2 cm in diameter. 
Results of surgery 
Ten of the 54 neck explorations were carried out elsewhere. 
Nine of these were performed at major teaching hospitals but on 
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Table 2 
Results of Surgery in MEN 1 (44 Operations, 42 Patients) 
Total 
Postoperative 
Elevation ACTC 
Postoperative Elevation IC 
Normal ACTC 
Preoperative 
elevation ACTC 30 3 (. 
Preoperative 
elevation IC 
normal ACTC 14 (1 2 
six occasions the diagnosis was simply primary hyperparathy-
roidism and the surgeon was unaware that the patient had MEN 
1. After nine of these 10 operations, postoperative ACTC mea-
surements showed persistent or recurrent elevation of ACTC. 
We have been unable to obtain a record of the postoperative cal-
cium levels in one case. 
There has not been a single negative neck exploration in a 
member of this family. At least one abnormal parathyroid has 
been identified on every occasion, regardless of whether the di-
agnosis was based on elevation of ACTC, PTH, or IC. 
Forty-four neck explorations for hyperparathyroidism in 42 
patients with MEN 1 from Tasman Family 1 have been carried 
out in the Royal Hobart Hospital. On 30 occasions both ACTC 
and IC were elevated. On 14 occasions patients had normal 
ACTC but elevated IC or PTH preoperatively. In follow-up 
varying from 1 to 16 years, persistent or recurrent elevation of 
ACTC has occurred only three times. On measurement of IC, a 
further eight patients have persistent elevations although ACTC 
is normal. Six of these are patients who had elevation of ACTC 
preoperatively. Subtotal parathyroidectomy has restored ACTC 
to normal levels but IC remains elevated. Two of these are pa-
tients whose ACTC was normal preoperatively. Therefore, in 
these two cases, measurement of ACTC showed normal levels 
both before and after surgery whereas measurement of IC 
showed elevated levels both before and after the identification 
and excision of 3.5 parathyroids (Table 2). 
Progress of untreated patients 
The majority of patients have been followed for more than 
three years. Three patients under the age of 30 with normal 
ACTC but elevated IC at the time of their initial test subse-
quently showed a rise both in IC and ACTC. In 27 patients, the 
situation of elevated IC but normal ACTC has been maintained 
at subsequent testing. A transient exception to this pattem has 
been observed in our patients during operation or intercurrent 
illness. The calcium has been monitored in one patient undergo-
ing surgery for testicular torsion, in one patient during hysterec-
tomy for fibroids, in one patient hospitalized for renal colic, and 
in one patient admitted for the treatment of pneumonia. In each 
ofthese patients ACTC became transiently elevated during their 
illness or operation but retumed to normal levels following reso-
lution of the illness or recovery from operation. IC levels re-
mained elevated throughout. 
Table 3 
Supporting Evidence for MEN 1 in 93 Patients with 
Elevated Serum Calcium 
Elevated ACTC Normal ACTC Elevated IC 
Lesions at other sites 
Affected offspring 
Confirmed by surgery 
or autopsy 
Lesions at other sites and/or 
affected offspring and/or 
confirmed by surgery 
Total 
44 (73%) 
23 
34 (57%) 
44 (73%) 
60 
23 (70%) 
9 
15 (45%) 
23 (70%) 
33 
Discussion 
Benson and colleagues (2) reported in 1987 following a study 
of three discriminants that IC is a more sensitive predictor of pri-
mary hyperparathyroidism than either ACTC or PTH. PTH 
assays have not been consistently valuable in our study. In the 
early years, the measurement of C-terminal was used and con-
sidered to be unsatisfactory. Later, the introduction of measur-
ing the intact molecule proved to be not always helpful in young 
patients with MEN 1 who have elevated ACTC or IC. Even a 
normal level of PTH is inappropriate in these patients and the 
diagnosis of hyperparathyroidism would only be considered 
doubtful if PTH were low or absent. 
Altogether, 23 (70%) of the 33 patients with elevated IC ei-
ther have additional evidence of MEN 1 in terms of having an-
other neuroendocrine lesion or having children with other neu-
roendocrine lesions or else have had the diagnosis of hyper-
parathyroidism confirmed by surgery. This is virtually identical 
with the findings in those with elevated ACTC (Table 3). We 
conclude that the diagnosis of MEN 1 is just as probable in pa-
tients with elevated IC but normal ACTC as in those with ele-
vated ACTC. 
It has only been possible to measure IC since the end of 1986 
and a larger study and prolonged follow-up is necessary to pro-
vide firm conclusions regarding the emerging pattem of calcium 
changes and PTH levels in teenagers as hyperparathyroidism 
develops. Initial results suggest that it is the normal pattem for 
IC to become elevated whilst both ACTC and PTH are within 
the normal range. We have not seen any patients with consistent 
elevation of ACTC but normal IC. With the passage of time, 
some patients progress to a situation where both ACTC and IC 
are elevated. In other patients IC is persistently elevated but 
ACTC remains normal throughout life except during periods of 
illness or stress. 
Moreover, the age distribution of elevated IC with normal 
ACTC (Table 1, Figure) indicates that if screening is based on 
ACTC then diagnosis may not simply be delayed but may never 
be establi.shed. Offspring may then be unaware of their family 
history. It is inconceivable that the diagnosis of insulinoma 
would have been missed for 12 years if patient 1548 had given a 
family history of hyperparathyroidism. Careful assessment of 
the pancreas, pituitary, adrenal, thymus, and bronchus where 
more serious lesions may develop will be omitted. 
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Failure to measure IC may adversely affect the management 
of intractable ulceration in patients with MEN 1. In this family, 
every patient with the ZE syndrome and raised serum gastrin 
also has an elevation of the serum calcium, but in four ofthe pa-
tients only IC was elevated and ACTC was normal. In these four 
patients, previously intractable ulceration responded to parathy-
roidectomy without the necessity for gastric surgery. On the 
other hand, a member of Tasman Family 1 who had migrated to 
another country underwent three major gastric operations, cul-
minating in total gastrectomy for bleeding ulcer without recog-
nition ofher parathyroid hyperplasia. She is not included in our 
series of 93 patients because IC was never measured and ACTC 
was normal. She clearly had hyperparathyroidism because at her 
death from metastasizing malignant carcinoid of the bronchus, 
postmortem revealed four hyperplastic parathyroid glands up to 
2 cm in diameter. A previous history of adrenal and pituitary 
adenomas had alerted her physicians to the likelihood of MEN 
1, but when both ACTC and PTH were found to be normal they 
considered the diagnosis of hyperparathyroidism as unproven. 
Our experience suggests that her IC would have been elevated 
had this measurement been undertaken and her intractable ulcer 
would probably have responded to parathyroidectomy. Inciden-
tally, this case history indicates that the finding of normal 
ACTC and PTH in the presence of indisputable hyperparathy-
roidism in a member of this family is not confined to our institu-
tion. 
An unwelcome aspect of this study from the surgical view-
point has been the finding that recurrence or persistence of hy-
percalcemia after parathyroidectomy is much more common 
than is apparent when only ACTC is measured. Rather than 
three recurrences in patients from our own unit identified on the 
basis of ACTC measurement, il has been found that IC remains, 
or has again become, elevated in 11 of 44 operations. Our initial 
experience of finding moderately enlarged glands, compared 
with those found in patients with elevation of ACTC, led to an 
earlier philosophy in the patients with normal ACTC of preserv-
ing the equivalent of one small gland to avoid hypoparathy-
roidism. It has now become apparent that these patients need to 
be dealt with just as radically as those with elevation of ACTC 
or elevation of IC will persist or recur. 
Several studies have reported a higher recurrence rate follow-
ing parathyroid surgery in patients with MEN 1 than in those 
with adenomas or hyperplasia from other causes. Following ten 
operations on members of this family outside our own unit, the 
recurrence rate has been at least 90%. Prinz et al (6) found a re-
currence rate of 33% whilst Rizzoli et al (7) reported 54% recur-
rence after one operation and 46% after a second neck explora-
tion in MEN 1 patients. 
All previous authors appear to have based their figures en-
tirely on the measurement of ACTC. Our experience suggests 
that the true recurrence rate may be much higher than even the 
unsatisfactory levels indicated by previous studies and that a 
radical surgical approach is essential in all patients with MEN 1. 
However, the main significance of the operative findings and 
postoperative .studies may be the indication that elevation of IC 
with normal ACTC reflects to some extent the quantity of 
hyperplastic parathyroid tissue. Measurement of ACTC estab-
40 
Elevated ACTC 
Elevated IC 
< 30 Yrs 30 - 49 Yrs 
Age Grouping 
50 -F Yrs 
Figure—Age grouping: The designated "elevated IC" group in-
dicates those with elevated IC hut normal ACTC. 
lishes the diagnosis of hyperparathyroidism in one-half of pa-
tients under the age of 30 and 65% at all ages when four hyper-
plastic glands are present. However, measurement of ACTC 
will only establish the diagnosis in one-fourth of patients with 
persistent hyperparathyroidism associated with one or less than 
one hyperplastic gland. If a similar situation applies to the early 
stages of sporadic adenomas, it is possible that ACTC is equally 
unsuitable to screen members of the general population with re-
nal calcuh, osteopenia, or recurrent pancreatitis. 
The finding that many MEN 1 patients have normal ACTC 
should not be interpreted as indicating that only a modest level 
of hypercalcemia is a constant finding in the syndrome. Three 
patients had ACTC levels between 3.5 and 3.9 mmol/L at first 
diagnosis with two requiring urgent treatment of acute hypercal-
cemic crisis. Moreover, a sudden rise of IC and a transient rise of 
ACTC have been observed in four patients after operation or 
during intercurrent illness, reinforcing the view that in MEN 1 
families it is highly desirable to identify all patients with hyper-
parathyroidism by including the measurement of IC in routine 
screening. 
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